Category: News

IntelliCell BioSciences, Inc. Announces Name Change From Media Exchange Group, Inc. & New Trading Symbol “SVFC”

IntelliCell BioSciences, Inc. Announces Name Change From Media Exchange Group, Inc. and New Trading Symbol “SVFC” NEW YORK, NY–(July 7, 2011 07:00 ET) – IntelliCell BioSciences, Inc. (OTCQB: SVFC) (PINKSHEETS: SVFC) and formerly (OTCQB: CWLC) (PINKSHEETS: CWLC) (“IntelliCell” or the “Company”), a leader in regenerative medicine and the manufacturing of stromal vascular fraction (SVF) containing adipose derived adult stem cells, today announced that it has changed its name from Media Exchange Group, Inc. to IntelliCell BioSciences, Inc., effective June 27, 2011. In connection with this name change to IntelliCell BioSciences, Inc., as of the open of trading on July 7,…

IntelliCell BioSciences, Inc. Announces It Will Open Adipose Tissue Processing Center in Houston

IntelliCell BioSciences, Inc. Announces It Will Open Adipose Tissue Processing Center in Houston NEW YORK, NY–(Aug 1, 2011 7:00:00 AM) – IntelliCell BioSciences, Inc. (OTCQB: SVFC) (PINKSHEETS: SVFC) (“IntelliCell” or the “Company”), a leader in regenerative medicine and the manufacturing of stromal vascular fraction (SVF) containing adipose derived adult stem cells, announced today it has signed an agreement to open an Adipose Stem Cell Processing Center in Houston, Texas in the next six weeks. This center will make adipose derived stem cells available for doctors in the metro Houston area. The use of autologous adipose (fat) stem cells for a…

IntelliCell BioSciences, Inc. Announces It Will Open Adipose Tissue Processing Center in Orlando

IntelliCell BioSciences, Inc. Announces It Will Open Adipose Tissue Processing Center in Orlando NEW YORK, NY–(Aug 3, 2011 11:11 AM) – IntelliCell BioSciences, Inc. (OTCQB: SVFC) (PINKSHEETS: SVFC) (“IntelliCell” or the “Company”), a leader in regenerative medicine and the manufacturing of stromal vascular fraction (SVF) containing adipose derived adult stem cells, announced today it has signed an agreement to open an Adipose Stem Cell Processing Center in Orlando, Florida in the next six weeks. This center will make adipose derived stem cells available for doctors in the metro Orlando area. The use of autologous adipose (fat) stem cells for a…

IntelliCell BioSciences, Inc. Announces It Will Open Adipose Tissue Processing Center in Denver

IntelliCell BioSciences, Inc. Announces It Will Open Adipose Tissue Processing Center in Denver NEW YORK, NY–(July 28, 2011 11:54 ET) – IntelliCell BioSciences, Inc. (OTCQB: SVFC) (PINKSHEETS: SVFC) (“IntelliCell” or the “Company”), a leader in regenerative medicine and the manufacturing of stromal vascular fraction (SVF) containing adipose derived adult stem cells, announced today it has signed an agreement to open an Adipose Stem Cell Processing Center in Denver, Colorado in the next six weeks. This center will make adipose derived stem cells available for doctors in the metro Denver area. The use of autologous adipose (fat) stem cells for a…

IntelliCell BioSciences’ Stem Cell Technology Validated by Merck Subsidiary

IntelliCell BioSciences’ Stem Cell Technology Validated by Merck Subsidiary NEW YORK, NY–(Jul 14, 2011 07:00 ET) – IntelliCell BioSciences, Inc. (OTCQB: SVFC) (PINKSHEETS: SVFC) (“IntelliCell” or the “Company”), a leader in regenerative medicine and the manufacturing of stromal vascular fraction (SVF) containing adipose derived adult stem cells, today announced that an antibody flow cytometry study of IntelliCell’s technology was performed by Millipore, a division of Merck, a life science leader providing cutting-edge technologies, tools and services for bioscience research and biopharmaceutical manufacturing. The results of the study conclude that IntelliCells manufactured by IntelliCell’s proprietary technology yield an average of 10…